Sjøstrøm J E, Kühler T, Larsson H
Department of Cell Biology, Preclinical Research and Development, Astra Hässle AB, Mölndal, Sweden.
Antimicrob Agents Chemother. 1997 Aug;41(8):1797-801. doi: 10.1128/AAC.41.8.1797.
Proton pump inhibitors of the benzimidazole type exert a specific antibacterial activity against Helicobacter pylori in vitro. In the present study, the basis for this selectivity was investigated, and in particular, various factors affecting the in vitro antibacterial activity of sulfide analogs of benzimidazoles were studied. Upon preincubation of omeprazole for a period of up to 72 h in a buffer at pH 7, a product was formed that was bactericidal for H. pylori but had no effect on urease activity. Sulfide constitutes the main end product of degradation. The sulfide analog of omeprazole (H 168/22) exerted a bactericidal activity specifically against both resting (in buffer) and growing (in broth) Helicobacter spp., and time-kill in buffer at pH 5 was enhanced compared to that at pH 7. There was no or very low covalent binding of 3H-labeled H 168/22 to Helicobacter spp. or to other gram-negative and gram-positive bacteria. In the presence of fetal calf serum (FCS) under the same conditions, binding was only slightly lowered while the killing activity was markedly reduced, indicating a probably nonspecific interaction with proteins and/or protection of bacterial target(s) by FCS. Addition of H 168/22 (four times the minimum bactericidal concentration [MBC]) to exponentially growing H. pylori immediately stopped growth, and after an incubation period of 20 h viable counts were reduced by >7 log10. One-hour exposure of H. pylori to the drug followed by repeated washing retarded growth by about 2 h, indicating that the effect is reversible after short-term exposure. MICs and MBCs of various sulfide structures were lower than those obtained in broth after the addition of the corresponding sulfoxide. Thus, the MBC of the sulfide structure of omeprazole against 140 clinical isolates of H. pylori ranged from 8 to 32 microg/ml, compared to an MBC of omeprazole of 32 to 128 microg/ml. A similar potency was also recorded against other helicobacters. In conclusion, formation of sulfides of benzimidazoles in culture media is the reason for the selective antibacterial effect against H. pylori. The sulfides rapidly exerted a reversible antibacterial activity, which was specific against both resting and growing Helicobacter spp. without any covalent protein binding.
苯并咪唑类质子泵抑制剂在体外对幽门螺杆菌具有特异性抗菌活性。在本研究中,对这种选择性的基础进行了研究,特别是对影响苯并咪唑硫化物类似物体外抗菌活性的各种因素进行了研究。将奥美拉唑在pH 7的缓冲液中预孵育长达72小时后,形成了一种对幽门螺杆菌具有杀菌作用但对脲酶活性无影响的产物。硫化物是降解的主要终产物。奥美拉唑的硫化物类似物(H 168/22)对静止(在缓冲液中)和生长(在肉汤中)的幽门螺杆菌属均具有特异性杀菌活性,与pH 7相比,在pH 5的缓冲液中的杀菌时间-杀灭曲线有所增强。3H标记的H 168/22与幽门螺杆菌属或其他革兰氏阴性和革兰氏阳性细菌没有或仅有非常低的共价结合。在相同条件下,在胎牛血清(FCS)存在下,结合仅略有降低,而杀灭活性则明显降低,表明可能与蛋白质发生非特异性相互作用和/或FCS对细菌靶点的保护作用。向指数生长的幽门螺杆菌中加入H 168/22(最低杀菌浓度[MBC]的四倍)立即停止生长,孵育20小时后活菌数减少>7个对数级。幽门螺杆菌暴露于该药物1小时后反复洗涤,生长延迟约2小时,表明短期暴露后效果是可逆的。各种硫化物结构的MIC和MBC低于加入相应亚砜后在肉汤中获得的数值。因此,奥美拉唑硫化物结构对140株临床分离的幽门螺杆菌的MBC范围为8至32μg/ml,而奥美拉唑的MBC为32至128μg/ml。对其他幽门螺杆菌也记录到了类似的效力。总之,培养基中苯并咪唑硫化物的形成是对幽门螺杆菌产生选择性抗菌作用的原因。硫化物迅速发挥可逆的抗菌活性,对静止和生长的幽门螺杆菌属均具有特异性,且无任何共价蛋白结合。